Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT01104155. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Purpose of This Study is to Investigate Two Different Dose Regimens of Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-small Cell Lung Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2, multicenter, randomized study of two different dose regimens of eribulin mesylate in combination with intermittent erlotinib in patients with previously treated, advanced non-small cell lung cancer.
Study identification
- NCT ID
- NCT01104155
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 123 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 22, 2010 (Actual)
- Primary completion
- Apr 7, 2011 (Actual)
- Completion
- Jan 18, 2017 (Actual)
- Last update posted
- Jun 22, 2023
2010 – 2017
United States locations
- U.S. sites
- 50
- U.S. states
- 16
- U.S. cities
- 50
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Bessemer | Alabama | — | — |
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Beverly Hills | California | — | — |
| Not listed | La Jolla | California | — | — |
| Not listed | Aurora | Colorado | — | — |
| Not listed | Boulder | Colorado | — | — |
| Not listed | Colorado Springs | Colorado | — | — |
| Not listed | Denver | Colorado | — | — |
| Not listed | Lakewood | Colorado | — | — |
| Not listed | Littleton | Colorado | — | — |
| Not listed | Lone Tree | Colorado | — | — |
| Not listed | Longmont | Colorado | — | — |
| Not listed | Parker | Colorado | — | — |
| Not listed | Thornton | Colorado | — | — |
| Not listed | Washington D.C. | District of Columbia | — | — |
| Not listed | Ocala | Florida | — | — |
| Not listed | Port Saint Lucie | Florida | — | — |
| Not listed | Kansas City | Kansas | — | — |
| Not listed | Overland Park | Kansas | — | — |
| Not listed | Shawnee Mission | Kansas | — | — |
| Not listed | Detroit | Michigan | — | — |
| Not listed | Columbia | Missouri | — | — |
| Not listed | Jefferson City | Missouri | — | — |
| Not listed | Kansas City | Missouri | — | — |
| Not listed | Lee's Summit | Missouri | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Elizabeth City | North Carolina | — | — |
| Not listed | Portland | Oregon | — | — |
| Not listed | Tualatin | Oregon | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | East Providence | Rhode Island | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Fort Worth | Texas | — | — |
| Not listed | Garland | Texas | — | — |
| Not listed | Plano | Texas | — | — |
| Not listed | Arlington | Virginia | — | — |
| Not listed | Chesapeake | Virginia | — | — |
| Not listed | Fairfax | Virginia | — | — |
| Not listed | Gainesville | Virginia | — | — |
| Not listed | Hampton | Virginia | — | — |
| Not listed | Leesburg | Virginia | — | — |
| Not listed | Newport News | Virginia | — | — |
| Not listed | Norfolk | Virginia | — | — |
| Not listed | Virginia Beach | Virginia | — | — |
| Not listed | Williamsburg | Virginia | — | — |
| Not listed | Winchester | Virginia | — | — |
| Not listed | Woodbridge | Virginia | — | — |
| Not listed | Spokane | Washington | — | — |
| Not listed | Vancouver | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01104155, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 22, 2023 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01104155 live on ClinicalTrials.gov.